,
Serge Clément,1,
Bernard Pajak,2
Viviane Pohl,1
Carine Maenhaut,1
Jacques E. Dumont,1 and
Stéphane Schurmans1*
Institut de Recherches Interdisciplinaires en Biologie Humaine et Moléculaire, Faculté de Médecine,1 Laboratoire de Physiologie Animale, Faculté des Sciences, Institut de Biologie et de Médecine Moléculaires, Université Libre de Bruxelles, Gosselies, Belgium2
Received 23 July 2004/ Returned for modification 24 August 2004/ Accepted 15 December 2004
Rhophilin 2 is a Rho GTPase binding protein initially isolated by differential screening of a chronically thyrotropin (TSH)-stimulated dog thyroid cDNA library. In thyroid cell culture, expression of rhophilin 2 mRNA and protein is enhanced following TSH stimulation of the cyclic AMP (cAMP) transduction cascade. Yeast two-hybrid screening and coimmunoprecipitation have revealed that the GTP-bound form of RhoB and components of the cytoskeleton are protein partners of rhophilin 2. These results led us to suggest that rhophilin 2 could play an important role downstream of RhoB in the control of endocytosis during the thyroid secretory process which follows stimulation of the TSH/cAMP pathway. To validate this hypothesis, we generated rhophilin 2-deficient mice and analyzed their thyroid structure and function. Mice lacking rhophilin 2 develop normally, have normal life spans, and are fertile. They have no visible goiter and no obvious clinical signs of hyper- or hypothyroidism. The morphology of thyroid cells and follicles in these mice were normal, as were the different biological tests performed to investigate thyroid function. Our results indicate that rhophilin 2 does not play an essential role in thyroid physiology.
J.B. and S.C. contributed equally to this work.
Present address: Medizinische Hochschule Hannover, Department of Gastroenterology, Hepatology and Endocrinology, 30623 Hannover, Germany.
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|